ODP · As filed with the SEC
ODP cash flow statement, by quarter
The statement as ODP presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS · USD
| USD | Q3 2025 3 months ended Sep 27, 2025 | Q2 2025 3 months ended Jun 28, 2025 | Q1 2025 3 months ended Mar 29, 2025 | Q4 2024 3 months ended Dec 28, 2024 | Q3 2024 3 months ended Sep 28, 2024 | Q2 2024† 3 months ended Jun 29, 2024 | Q1 2024 3 months ended Mar 30, 2024 | Q4 2023† 3 months ended Dec 30, 2023 |
|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||
| Net income (loss) | — | — | (29,000,000) | — | — | — | 15,000,000 | — |
| Loss from discontinued operations, net of tax | — | — | 0 | — | — | — | — | — |
| Net income (loss) from continuing operations | — | — | (29,000,000) | — | — | — | 15,000,000 | — |
| Adjustments to reconcile net income (loss) to net cash provided by operating activities: | ||||||||
| Depreciation and amortization | — | — | 27,000,000 | — | — | — | 29,000,000 | — |
| Charges for losses on receivables and inventories | — | — | 4,000,000 | — | — | — | 9,000,000 | — |
| Asset impairments | — | — | 38,000,000 | — | — | — | 6,000,000 | — |
| Compensation expense for share-based payments | — | — | 7,000,000 | — | — | — | 11,000,000 | — |
| Deferred income taxes and deferred tax asset valuation allowances | — | — | (15,000,000) | — | — | — | (8,000,000) | — |
| Changes in working capital and other operating activities | — | — | 25,000,000 | — | — | — | (24,000,000) | — |
| Net cash provided by operating activities of continuing operations | — | — | 57,000,000 | — | — | — | 38,000,000 | — |
| Net cash provided by operating activities | — | — | 57,000,000 | — | — | — | 38,000,000 | — |
| Cash flows from investing activities: | ||||||||
| Capital expenditures | — | — | (21,000,000) | — | — | — | (35,000,000) | — |
| Proceeds from disposition of assets | — | — | — | — | — | — | 1,000,000 | — |
| Settlement of company-owned life insurance policies | — | — | 9,000,000 | — | — | — | — | — |
| Net cash used in investing activities of continuing operations | — | — | (12,000,000) | — | — | — | (34,000,000) | — |
| Net cash used in investing activities of discontinued operations | — | — | (2,000,000) | — | — | — | — | — |
| Net cash used in investing activities | — | — | (14,000,000) | — | — | — | (34,000,000) | — |
| Cash flows from financing activities: | ||||||||
| Payments on credit facilities and debt retirement | — | — | (219,000,000) | — | — | — | — | — |
| Borrowings under credit facilities | — | — | 201,000,000 | — | — | — | — | — |
| Net payments on other long and short-term borrowings | — | — | (3,000,000) | — | — | — | (3,000,000) | — |
| Debt retirement | — | — | — | — | — | (112,000,000)† | (128,000,000) | 0† |
| Debt issuance | — | — | — | — | — | 171,000,000† | 75,000,000 | 0† |
| Share purchases for taxes, net of proceeds from employee share-based transactions | — | — | (2,000,000) | — | — | — | (6,000,000) | — |
| Repurchase of common stock for treasury | — | — | — | — | — | — | (50,000,000) | — |
| Other financing activities | — | — | (1,000,000) | — | — | — | (1,000,000) | — |
| Net cash used in financing activities of continuing operations | — | — | (24,000,000) | — | — | — | (113,000,000) | — |
| Net cash used in financing activities | — | — | (24,000,000) | — | — | — | (113,000,000) | — |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | — | — | — | — | — | — | (1,000,000) | — |
| Net increase (decrease) in cash, cash equivalents and restricted cash | — | — | 19,000,000 | — | — | — | (110,000,000) | — |
| Cash, cash equivalents and restricted cash at beginning of period | 182,000,000 | 190,000,000 | 171,000,000 | 197,000,000 | 193,000,000 | 285,000,000 | 395,000,000 | 388,000,000 |
| Cash, cash equivalents and restricted cash at end of period | 187,000,000 | 182,000,000 | 190,000,000 | 171,000,000 | 197,000,000 | 193,000,000 | 285,000,000 | 395,000,000 |
| Cash, cash equivalents and restricted cash at end of period — continuing operations | — | — | — | 171,000,000 | — | — | — | 395,000,000 |
| Supplemental information on non-cash investing and financing activities | ||||||||
| Right-of-use assets obtained in exchange for new operating lease liabilities | — | — | 22,000,000 | — | — | — | 63,000,000 | — |
| Right-of-use assets obtained in exchange for new finance lease liabilities | — | — | 5,000,000 | — | — | — | 6,000,000 | — |
| Interest paid | — | — | 5,000,000 | — | — | — | 3,000,000 | — |
| Cash taxes paid, net | — | — | 4,000,000 | — | — | — | 1,000,000 | — |
| Earn-out receivable obtained from disposition of discontinued operations | — | — | — | — | — | — | — | 0† |
† Derived: worked out from the filings, not stated in them. A fourth quarter is the 10-K year less the nine months in the third-quarter 10-Q; a quarter of cash flows is year to date less the prior year to date.
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.